Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS2W
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -2.6 %
2W -1.2 %
1M -2.6 %
3M 127.4 %
6M 104.2 %
9M 125.8 %
1Y -38.9 %
Alpha
-27.5%
Beta
-0.5
sharpe-R
-0.28
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:01:03
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -75.48%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
TDOC Teladoc Health, Inc. Equity Buy 10.58% 37.79%
ALDX Aldeyra Therapeutics, Inc. Equity Buy 10.58% 13.66%
BCRX BioCryst Pharmaceuticals, Inc. Equity Buy 10.58% 5.11%
ANIP ANI Pharmaceuticals, Inc. Equity Buy 10.58% -2.11%
PAHC Phibro Animal Health Corporation Equity Buy 10.58% 4.84%
EW Edwards Lifesciences Corporation Equity Buy 10.58% 0.49%
HCSG Healthcare Services Group, Inc. Equity Buy 10.58% -4.16%
CERS Cerus Corporation Equity Buy 10.58% 2.78%
OFIX Orthofix Medical Inc. Equity Buy 10.58% 0%
IBRX ImmunityBio, Inc. Equity Buy 10.58% 0%
MCRB Seres Therapeutics, Inc. Equity Sell 12.51% -3.4%
CNMD CONMED Corporation Equity Sell -5.49% 6.25%
MOH Molina Healthcare, Inc. Equity Sell -5.59% 4.47%
CUTR Cutera, Inc. Equity Sell -9.23% -17.07%
The percentage of cash held in the portfolio is: 2%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 10.58% 37.79%
ALDX Aldeyra Therapeutics, Inc. Buy 10.58% 13.66%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.58% 5.11%
ANIP ANI Pharmaceuticals, Inc. Buy 10.58% -2.11%
PAHC Phibro Animal Health Corporation Buy 10.58% 4.84%
EW Edwards Lifesciences Corporation Buy 10.58% 0.49%
HCSG Healthcare Services Group, Inc. Buy 10.58% -4.16%
CERS Cerus Corporation Buy 10.58% 2.78%
OFIX Orthofix Medical Inc. Buy 10.58% 0%
IBRX ImmunityBio, Inc. Buy 10.58% 0%
MCRB Seres Therapeutics, Inc. Sell 12.51% -3.4%
CNMD CONMED Corporation Sell -5.49% 6.25%
MOH Molina Healthcare, Inc. Sell -5.59% 4.47%
CUTR Cutera, Inc. Sell -9.23% -17.07%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ANIP Sell -1.28%
HCSG Sell -1.51%
EW Sell -2.37%
CERS Sell -2.38%
ALDX Sell -3.19%
PAHC Sell -3.66%
TDOC Sell -4.02%
BCRX Sell -4.25%
OFIX Buy 7.43%
IBRX Buy 7.43%
2025-02-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 14.61% 37.79%
ALDX Aldeyra Therapeutics, Inc. Buy 13.77% 13.66%
BCRX BioCryst Pharmaceuticals, Inc. Buy 14.83% 5.11%
ANIP ANI Pharmaceuticals, Inc. Buy 11.86% -2.11%
PAHC Phibro Animal Health Corporation Buy 14.24% 4.84%
EW Edwards Lifesciences Corporation Buy 12.95% 0.49%
CERS Cerus Corporation Buy 12.96% 2.78%
HCSG Healthcare Services Group, Inc. Buy 12.09% -4.16%
OFIX Orthofix Medical Inc. Buy 3.15% 0%
IBRX ImmunityBio, Inc. Buy 3.15% 0%
MCRB Seres Therapeutics, Inc. Sell 12.51% -3.4%
CNMD CONMED Corporation Sell -5.49% 6.25%
MOH Molina Healthcare, Inc. Sell -5.59% 4.47%
CUTR Cutera, Inc. Sell -9.23% -17.07%
The percentage of cash held in the portfolio is: -5.8%
New Assets Added
  • OFIX
  • IBRX
Assets Removed
Asset Action Perf %
VNDA Sell All -5.76%
PACB Buy All -28.47%
Assets Rebalanced
None
2025-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 13.49% 29.9%
ALDX Aldeyra Therapeutics, Inc. Buy 13.45% 13.31%
BCRX BioCryst Pharmaceuticals, Inc. Buy 14.16% 2.44%
ANIP ANI Pharmaceuticals, Inc. Buy 11.67% -1.66%
PAHC Phibro Animal Health Corporation Buy 13.63% 2.48%
VNDA Vanda Pharmaceuticals Inc. Buy 11.89% 0.21%
EW Edwards Lifesciences Corporation Buy 12.65% 0.24%
CERS Cerus Corporation Buy 12.35% 0%
HCSG Healthcare Services Group, Inc. Buy 12.35% 0%
MCRB Seres Therapeutics, Inc. Sell 12.35% -4.27%
PACB Pacific Biosciences of California, Inc. Sell -6.12% -2.78%
CNMD CONMED Corporation Sell -5.48% 4.44%
MOH Molina Healthcare, Inc. Sell -5.45% 5.03%
CUTR Cutera, Inc. Sell -7.91% -2.44%
The percentage of cash held in the portfolio is: -3.05%
New Assets Added
  • HCSG
  • CERS
  • MCRB
Assets Removed
None
Assets Rebalanced
None
2025-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 12.65% 20.67%
ALDX Aldeyra Therapeutics, Inc. Buy 12.65% 5.52%
BCRX BioCryst Pharmaceuticals, Inc. Buy 14.23% 1.97%
VNDA Vanda Pharmaceuticals Inc. Buy 12.14% 1.28%
ANIP ANI Pharmaceuticals, Inc. Buy 11.88% -0.85%
PAHC Phibro Animal Health Corporation Buy 13.45% 0.08%
EW Edwards Lifesciences Corporation Buy 12.75% 0%
MCRB Seres Therapeutics, Inc. Sell -6.1% -1.54%
PACB Pacific Biosciences of California, Inc. Sell -5.68% 5.56%
MOH Molina Healthcare, Inc. Sell -5.42% 6.47%
CNMD CONMED Corporation Sell -5.38% 7.21%
CUTR Cutera, Inc. Sell -7.8% 0%
The percentage of cash held in the portfolio is: 40.62%
New Assets Added
  • EW
Assets Removed
Asset Action Perf %
LGND Sell All -5.47%
Assets Rebalanced
None
2025-02-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 12.95% 25.38%
ALDX Aldeyra Therapeutics, Inc. Buy 12.28% 3.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 14.35% 4.41%
VNDA Vanda Pharmaceuticals Inc. Buy 11.88% 0.64%
ANIP ANI Pharmaceuticals, Inc. Buy 11.74% -0.56%
LGND Ligand Pharmaceuticals Incorporated Buy 13.35% -4.3%
PAHC Phibro Animal Health Corporation Buy 14.07% 6.27%
MCRB Seres Therapeutics, Inc. Sell -5.87% 0.82%
PACB Pacific Biosciences of California, Inc. Sell -5.47% 7.64%
MOH Molina Healthcare, Inc. Sell -5.47% 4.19%
CNMD CONMED Corporation Sell -5.51% 3.41%
CUTR Cutera, Inc. Sell -7.68% 0%
The percentage of cash held in the portfolio is: 39.38%
New Assets Added
  • CUTR
Assets Removed
Asset Action Perf %
EW Sell All -2.27%
ACRS Sell All -14.4%
ALT Sell All -10.01%
NRC Buy All -6.12%
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 12.65% -3.05%
TDOC Teladoc Health, Inc. Buy 12.86% 24.52%
ALDX Aldeyra Therapeutics, Inc. Buy 12.26% 3.85%
BCRX BioCryst Pharmaceuticals, Inc. Buy 13.92% 1.28%
ACRS Aclaris Therapeutics, Inc. Buy 12.75% -3.11%
ALT Altimmune, Inc. Buy 12.75% -4.72%
VNDA Vanda Pharmaceuticals Inc. Buy 12.08% 2.35%
ANIP ANI Pharmaceuticals, Inc. Buy 11.87% 0.6%
LGND Ligand Pharmaceuticals Incorporated Buy 13.63% -2.25%
PAHC Phibro Animal Health Corporation Buy 12.75% -3.62%
NRC National Research Corporation Sell -6.07% -1.09%
MCRB Seres Therapeutics, Inc. Sell -5.74% 2.93%
PACB Pacific Biosciences of California, Inc. Sell -6.41% -8.33%
MOH Molina Healthcare, Inc. Sell -5.68% 0.36%
CNMD CONMED Corporation Sell -5.63% 1.38%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
BCRX Buy 0.8%
LGND Buy 1.22%
ACRS Buy 1.31%
PAHC Buy 1.38%
ALT Buy 1.5%
EW Buy 3.14%

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings